Niyati Skaria
Pediatric Endocrinology · Sacramento, CANPI 1720235146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2022 at $1,432 and has fallen 52.8% since, to $676 in 2025.
Across 379 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Tandem Diabetes Care, Inc.$745
- AstraZeneca$396
- Novo Nordisk$359
- Insulet Corporation$318
- Abbott$268
- plus $2K from 25 others
What the payments were for
- Food & beverage$6,35899%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 170 | $2,016 |
| Tandem Diabetes Care, Inc. | 30 | $745 |
| AstraZeneca | 13 | $396 |
| Novo Nordisk | 26 | $359 |
| Insulet Corporation | 14 | $318 |
| Abbott | 12 | $268 |
| Ascendis Pharma Endocrinology Inc | 6 | $267 |
| Biomarin Pharmaceutical Inc. | 16 | $231 |
| Dexcom, Inc. | 11 | $212 |
| Tolmar Pharmaceuticals, Inc. | 18 | $175 |
| Azurity Pharmaceuticals, Inc. | 7 | $159 |
| Lilly USA, LLC | 7 | $152 |
| Companion Medical, Inc. | 6 | $135 |
| Neurocrine Biosciences, Inc. | 1 | $119 |
| Tolmar, Inc. | 5 | $115 |
| Pfizer | 6 | $107 |
| Mannkind Corporation | 4 | $89 |
| Ferring Pharmaceuticals Inc. | 5 | $83 |
| Ipsen Biopharmaceuticals, Inc | 3 | $78 |
| Medtronic(2 entities) | 4 | $74 |
| Zealand Pharma US, Inc. | 3 | $52 |
| BETA Bionics, Inc. | 1 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Krystal Biotech Inc | 1 | $31 |
| Soleno Therapeutics, Inc. | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Embecta Corp. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,428 in reported general payments places this provider in the 80th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Sacramento
- Gnanagurdasan PrakasamSacramento$805K
- Ulhas NadgirSacramento$14K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
- Stephen GitelmanSan Francisco$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.